Download Files:
Products Details
Product Description
– HCV-IN-34 (compound 3i) is an orally active and potent HCV entry inhibitor. HCV-IN-35 shows excellent antiviral activity, with an EC50 of 0.010 μM and a CC50 (half-maximal cytotoxic concentration) of 8.23 μM[1].
Web ID
– HY-144107
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C31H36ClN5
References
– [1]Wang Y, Li J, Tan J, Yang B, Quan Y, Peng Z, Li Y, Li Z. Design, Synthesis, and Biological Evaluation of 2-((4-Bisarylmethyl-piperazin-1-yl)methyl)benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65(3):2107-2121.
CAS Number
– 2425805-22-5
Molecular Weight
– 514.10
SMILES
– N#CC1=CC=C(N2CCN(C)CCC2)C=C1CN3CCN(C(C4=CC=C(Cl)C=C4)C5=CC=CC=C5)CC3
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HCV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
